Work

miR-150 inhibitor ameliorates adriamycin-induced focal segmental glomerulosclerosis

Year: 2019

Type: article

Source: Biochemical and Biophysical Research Communications

DOI: 10.1016/j.bbrc.2019.11.096

Authors: Huimeng Qi, Jingqi Fu, Junjun Luan, Congcong Jiao, Xiangfei Cui, Xiangyan Cao, Yixiao Zhang, Yanqiu Wang, Jeffrey B. Kopp, Jingbo Pi, Hua Zhou

Institutions: Sheng Jing Hospital, First Hospital of China Medical University, China Medical University, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases

Language: English

Topic: Renal Diseases and Glomerulopathies

Subfield: Nephrology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Key Research and Development Program of China, National Key Research and Development Program of China Stem Cell and Translational Research

Awards: G4327078653, G6954744754

OpenAlex ID: W2991545250

FWCI: 1.543

Cites: 28

Cited by: 19

Related to: 10